ARPA-H's Open Door: The Mission-Office ISOs, an August 9 Mental-Illness Notice, and Why the Solution Summary Is the Whole Game

Most federal health research money runs through NIH, on a fixed calendar, judged by peer-review study sections against detailed criteria. ARPA-H — the Advanced Research Projects Agency for Health, stood up in 2022 on DARPA's model — runs on almost the opposite logic, and a cluster of currently open opportunities makes the difference concrete. Four Mission Office "Innovative Solution Openings" accept ideas year-round, and a Special Notice on serious mental illness (ARPA-H-SN-26-156) closes August 9, 2026. Understanding how these work is the difference between wasting a beautifully written proposal and getting a program manager to pick up the phone.

The core fact to internalize: at ARPA-H, you do not start by writing a proposal. You start by writing a Solution Summary, and a full proposal submitted without an invitation "may be rejected." The Solution Summary is the whole game. Everything else follows from getting that short document in front of the right program manager and getting a "yes, tell us more" back.

The four Mission Office ISOs

ARPA-H organizes its work under four mission offices, each with a standing ISO that stays open and accepts white-paper-style Solution Summaries against broad themes rather than narrow topics:

• Health Science Futures Office (ARPA-H-SOL-24-104) — research that removes scientific and technological limitations across disease areas; the platform-and-tools office.
• Proactive Health Office (ARPA-H-SOL-24-106) — preventive programs that keep people out of the clinical system in the first place. This is the office running the mental-illness Special Notice.
• Resilient Systems Office (ARPA-H-SOL-24-103) — robust health-care systems that hold up under stress, from supply chains to care delivery.
• Scalable Solutions Office (ARPA-H-SOL-24-105) — solutions that reach across geography and manufacturing, so a breakthrough works in a rural clinic and not just an academic medical center.

Alongside the standing ISOs, ARPA-H runs named programs — FASTPASS, HEARING, IGoR, REST — and exploratory topics like TIGAR and BRAINS, each announced as its own limited-window ISO. There's also an active 2026 SBIR/STTR set of topics for small businesses, and Special Notices like the mental-illness one that carve a specific, deadlined ask out of a mission office's broad remit.

The August 9 Special Notice: serious mental illness

ARPA-H-SN-26-156, issued under the Proactive Health Office ISO, seeks approaches to accelerate medical treatments for serious mental illness, with Solution Summaries due August 9, 2026. A Special Notice is ARPA-H's way of signaling active, focused interest: rather than waiting for the field to bring ideas against a broad theme, the agency names a problem it wants solved now and sets a date. For applicants, that is a gift — it removes the guesswork about whether a program manager is currently receptive to a topic.

Serious mental illness is a characteristically ARPA-H target: high burden, decades of incremental progress, and a treatment landscape where the agency's "durable, transformative" mandate — as opposed to NIH's steady advancement of the science — has room to matter. The agency is not looking for another mechanistic study. It is looking for a credible path to a treatment that works at a scale and speed the current pipeline hasn't delivered.

Why the Solution Summary changes the strategy

The two-step process is the single most important thing to understand about applying to ARPA-H, and it inverts the habits that NIH trains into researchers. For a Mission Office ISO, you submit a Solution Summary first; ARPA-H provides written feedback; and only with a favorable response do you submit a full proposal. Submitting a full proposal cold isn't just weaker — it can be rejected outright for skipping the step.

This rewards a different skill than a classic grant. An NIH R01 rewards comprehensive rigor — every alternative addressed, every pitfall anticipated, twelve dense pages. A Solution Summary rewards a sharp, quantified pitch: here is the problem, here is why current approaches fail, here is our specific solution, here is the metric that would prove it worked, and here is why our team can deliver it on an aggressive timeline. Program managers are reading for a fundable program, not a fundable study — something with milestones, go/no-go decisions, and a transition path to real-world use.

Three things separate the summaries that earn an invitation:

1. A quantified, defended metric of success. ARPA-H program managers think in terms of measurable leaps. "Improve outcomes" fails; "reduce time-to-effective-treatment for serious mental illness from months to days, validated in a defined cohort" is the register that gets a response.

2. Genuine transformation, not increment. The agency exists to fund what NIH's incremental mechanisms won't. A summary that reads like a strong R01 is, paradoxically, a weak ARPA-H pitch — it belongs at NIH. The question a program manager asks is whether success would change the field, not advance it.

3. A team and plan that can execute on an ARPA-H clock. These are managed programs with milestones and active oversight, closer to a contract than a grant. Reviewers weigh whether you can hit dates, integrate across disciplines, and move a result toward deployment — not just generate knowledge.

How ARPA-H fits the rest of the 2026 landscape

ARPA-H's structure looks especially attractive against this year's federal backdrop. NIH is absorbing a simplified three-factor review framework and the SimplerNOFO overhaul, and the broader federal grant system faces compressed windows and a shrinking pool of posted opportunities. ARPA-H's year-round ISOs cut against that grain: there is no single annual deadline to miss, and the low-cost first step — a Solution Summary rather than a full proposal — lets a team test an idea against a program manager's appetite before committing weeks of writing.

That is the practical opportunity. Because the entry cost is a short document and the mission-office ISOs never close, ARPA-H is one of the few federal channels where an organization can run cheap, fast experiments: float three distinct Solution Summaries across three mission offices, see which draws written interest, and invest the full-proposal effort only where a program manager has signaled a green light. In a year when most federal windows are narrowing, that optionality is rare.

For small businesses, the 2026 SBIR/STTR topics add a parallel, non-dilutive path with its own two-step Solution Summary → technical-presentation flow and support for Phase I, Direct-to-Phase II, and Fast-Track awards — worth pairing with the mission-office route rather than treating as an either/or.

The takeaway

ARPA-H is not NIH with a different logo. It funds durable, transformative leaps through managed programs, it accepts ideas year-round through four Mission Office ISOs, and it gates everything behind a Solution Summary that most applicants underinvest in because it looks small. The August 9 Special Notice on serious mental illness is a concrete, deadlined instance of the agency naming a problem and inviting sharp, quantified pitches. Treat the Solution Summary as the real competition, write it as a fundable program rather than a fundable study, and use the year-round ISOs to test ideas cheaply before committing to a full proposal. That is how ARPA-H's open door actually opens.